Join
Live feed
·
PRReleasevia Quantisnow
Iterum Therapeutics plc logo

Iterum Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem

ByQuantisnow·Wall Street's wire, on your screen.
ITRM· Iterum Therapeutics plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ITRM (Iterum Therapeutics plc) and more on Quantisnow.